We boldly inferred that there may be a positive regulatory relationship between CDKN2A and DDX11-AS1, and that silencing DDX11-AS1 can indirectly inhibit the CDKN2A expression, thereby increasing the role of copper loading in tumor cells, promoting cuproptosis, and increasing tumor cell apoptosis. Here, CDKN2A is linked to neoplasm.